n = 238 | |
---|---|
Time since HIV diagnosis, n (%) | |
≤ 1 year | 60 (25.2) |
2–5 years | 41 (17.2) |
6–10 years | 37 (15.6) |
≥ 11 | 100 (42) |
Comorbidities, yes (%) | |
Hypertension | 28 (11.8) |
Osteoporosis | 12 (5.0) |
Asthma | 8 (3.4) |
Diabetes | 6 (2.5) |
Dyslipidemia | 7 (2.9) |
Cancer | 5 (2.1) |
STDs history, yes (%) | |
Syphilis | 46 (19.3) |
Genital HPV | 34 (14.3) |
Gonorrhea | 6 (2.5) |
Hepatitis B | 6 (2.5) |
Hepatitis C | 3 (1.3) |
Genital herpes | 3 (1.3) |
AIDS-associated diseases history, yes (%) | |
Pulmonary TB | 14 (5.9) |
Toxoplasmic encephalitis | 10 (4.2) |
Kaposi’s sarcoma | 7 (2.9) |
Histoplasmosis | 8 (3.4) |
Cryptococcosis | 4 (1.7) |
Ocular cytomegalovirus | 4 (1.7) |
Nodal TB | 3 (1.3) |
Recommended vaccination history | n = 210 |
Hepatitis B vaccine, yes (%) | 122 (58.1) |
Influenza vaccine, yes (%) | 101 (48.1) |
Pneumococcal vaccine, yes (%) | 73 (34.8) |